These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 3705441)
1. Use of drug imprints. Bobbink S; Williams D; Robertson WO Vet Hum Toxicol; 1986 Apr; 28(2):160. PubMed ID: 3705441 [No Abstract] [Full Text] [Related]
2. Decoding "drug imprints" at the millennium: a proposal to increase accuracy and reduce costs. Marder S; Winkler T; Tadaki K; Bobbink S; Robertson WO Vet Hum Toxicol; 2001 Feb; 43(1):46-7. PubMed ID: 11205080 [TBL] [Abstract][Full Text] [Related]
3. Drug imprinting ('unit labeling')--an update and a plea! Chi B; Serafin D; Robertson WO Vet Hum Toxicol; 2003 Feb; 45(1):1-2. PubMed ID: 12583685 [No Abstract] [Full Text] [Related]
4. Measuring poison center service quality. Bobbink S; Knight L; Baxter L; Robertson WO Vet Hum Toxicol; 1986 Dec; 28(6):576. PubMed ID: 3788047 [No Abstract] [Full Text] [Related]
5. Drug information resources for treatment of acute drug overdose. Comstock EG Drug Inf J; 1975; 9(2-3):81-8. PubMed ID: 10236983 [No Abstract] [Full Text] [Related]
7. [Industrial secrecy and anti-poison centers]. Demozay D; Vincent V Eur J Toxicol Hyg Environ; 1973; 6(6):266-74. PubMed ID: 4794473 [No Abstract] [Full Text] [Related]
8. [Poison control center]. Visakorpi JK Duodecim; 1971; 87(17):1178-9. PubMed ID: 5131494 [No Abstract] [Full Text] [Related]
9. [Labeling of non-prescription drugs potentially harmful to children]. Edner I; Ferngren H; Hemström I Lakartidningen; 1966 Nov; 63():Suppl 2:36-43. PubMed ID: 5979925 [No Abstract] [Full Text] [Related]
10. A needed technical fix? Robertson WO Vet Hum Toxicol; 2000 Apr; 42(2):118-9. PubMed ID: 10750184 [No Abstract] [Full Text] [Related]
11. Washington's ER physicians' perceptions of poison centers. Misra S; Haulman J; Robertson WO Vet Hum Toxicol; 1993 Apr; 35(2):164-5. PubMed ID: 8470363 [No Abstract] [Full Text] [Related]
12. Comparison of poison control statutes in the United States. Russell SL; Czajka PA Am J Hosp Pharm; 1984 Mar; 41(3):481-4. PubMed ID: 6702852 [TBL] [Abstract][Full Text] [Related]
13. Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. A pharmaceutical industry perspective on drug labeling. Robinson DS Psychopharmacol Bull; 1994; 30(1):23-5. PubMed ID: 7972625 [No Abstract] [Full Text] [Related]
14. 10 minutes with CHEMTREC. Interview by Paula Hess. Butters T Emerg Med Serv; 1994 Nov; 23(11):27-8. PubMed ID: 10137714 [No Abstract] [Full Text] [Related]
15. Advantages and disadvantages of combining poison control and drug information centers. Troutman WG; Wanke LA Am J Hosp Pharm; 1983 Jul; 40(7):1219-22. PubMed ID: 6881165 [TBL] [Abstract][Full Text] [Related]
16. [Current status of cosmetic product regulation]. Pochet A Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S46-54. PubMed ID: 17563715 [No Abstract] [Full Text] [Related]
17. Role of US poison centers in adverse drug reactions monitoring. Chyka PA Vet Hum Toxicol; 1999 Dec; 41(6):400-2. PubMed ID: 10592954 [TBL] [Abstract][Full Text] [Related]
18. [Quality control in the pharmaceutical industry]. Sloot HA Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061 [No Abstract] [Full Text] [Related]
19. [Use of different drug form identification systems]. Panas M; Jawień W Przegl Lek; 2001; 58(4):378-9. PubMed ID: 11450376 [TBL] [Abstract][Full Text] [Related]